PARP Inhibitors: Extending Benefit Beyond BRCA Mutant Cancers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0968
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)